Histamine in chronic allergic responses

Journal of Investigational Allergology and Clinical Immunology

Volumn 15, Issue 1, 2005, Pages 1-8

  Jutel, M ^a,b   Blaser, K ^a   Akdis, Cezmi A ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Airway function; Allergy; Antibodies; Dendritic cells; Histamine; Histamine receptors; T cells; T regulatory cells; Tolerance

Indexed keywords

ANTIHISTAMINIC AGENT; BETA CHEMOKINE; BETA GLUCURONIDASE; BETAHISTINE; CALCIUM ION; CIMETIDINE; CYCLIC AMP; EOTAXIN; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTAMINE RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMPROMIDINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PADGEM PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC REACTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; DENDRITIC CELL; EFFECTOR CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RECEPTOR AFFINITY; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

HISTAMINE; HUMANS; HYPERSENSITIVITY; RECEPTORS, HISTAMINE; T-LYMPHOCYTES;

EID: 17444402444     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Dale HH, Laidlaw PP. Further observations on the action of b-imidazolylethylamine. J Physiol 1911; 43:182-95.
2. Milligan G, Bond R, Lee M. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 1995; 16:10-3.
3. Leurs R, Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002; 32(4):489-98.
4. Dimitriadou V, Rouleau A, Dam Trung Tuong M, Newlands GJ, Miller HR, Luffau G, Schwartz JC, Garbarg M. Functional relationship between mast cells and C-sensitive nerve fibres evidenced by histamine H3-receptor modulation in rat lung and spleen. Clin Sci (Lond) 1994; 87(2):151-63.
5. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000; 279(2):615-20.
6. Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, Mannan IJ, Boyce R, Alston J, Tierney LA, Li X, Herrity NC, Vawter L, Sarau HM, Ames RS, Davenport CM, Hieble JP, Wilson S, Bergsma DJ, Fitzgerald LR. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 2001; 59(3):434-41.
7. Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung WP, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 2004; 309(1):404-13.
8. Jablonowski JA, Grice CA, Chai W, Dvorak CA, Venable JD, Kwok AK, Ly KS, Wei J, Baker SM, Desai PJ, Jiang W, Wilson SJ, Thurmond RL, Karlsson L, Edwards JP, Lovenberg TW, Carruthers NI. The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 2003; 46(19):3957-60.
9. Simons FE. Comparative pharmacology of H1 antihistamines: clinical relevance. Am J Med 2002; 113 Suppl 9A:38S-46S.
10. Jutel M, Watanabe T, Akdis M, Blaser K, Akdis CA. Immune regulation by histamine. Curr Opin Immunol 2002; 14(6):735-40.
11. Akdis CA, Blaser K. Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol 2003; 112(1):15-22.
12. Vannier E, Dinarello CA. Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist. J Clin Invest 1993; 92(1):281-7.
13. Meretey K, Falus A, Taga T, Kishimoto T. Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines. Agents Actions 1991; 33(1-2):189-91.
14. Jeannin P, Delneste Y, Gosset P, Molet S, Lassalle P, Hamid Q, Tsicopoulos A, Tonnel AB. Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994; 84(7):2229-33.
15. Bayram H, Devalia JL, Khair OA, Abdelaziz MM, Sapsford RJ, Czarlewski W, Campbell AM, Bousquet J, Davies RJ. Effect of loratadine on nitrogen dioxide-induced changes in electrical resistance and release of inflammatory mediators from cultured human bronchial epithelial cells. J Allergy Clin Immunol 1999; 104(1):93-9.
16. Fujikura T, Shimosawa T, Yakuo I. Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa. J Allergy Clin Immunol 2001; 107(1):123-8.
17. Lo WW, Fan TP. Histamine stimulates inositol phosphate accumulation via the H1-receptor in cultured human endothelial cells. Biochem Biophys Res Commun 1987; 148(1):47-53.
18. Kubes P, Kanwar S. Histamine induces leukocyte rolling in post-capillary venules. A P-selectin-mediated event. J Immunol 1994; 152(7):3570-7.
19. Yamaki K, Thorlacius H, Xie X, Lindbom L, Hedqvist R, Raud J. Characteristics of histamine-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br J Pharmacol 1998; 123(3):390-9.
20. Schaefer U, Schmitz V, Schneider A, Neugebauer E. Histamine induced homologous and heterologous regulation of histamine receptor subtype mRNA expression in cultured endothelial cells. Shock 1999; 12(4):309-15.
21. Fadel R, Herpin-Richard N, Rihoux JP, Henocq E. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 1987; 17(4):373-9.
22. Clark RA, Sandler JA, Gallin JI, Kaplan AP. Histamine modulation of eosinophil migration. J Immunol 1977; 118(1):137-45.
23. O'Reilly M, Alpert R, Jenkinson S, Gladue RP, Foo S, Trim S, Peter B, Trevethick M, Fidock M. Identification of a histamine H4 receptor on human eosinophils-role in eosinophil chemotaxis. J Recept Signal Transduct Res 2002; 22(1-4):431-48.
24. Buckland KF, Williams TJ, Conroy DM. Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br J Pharmacol 2003; 140(6):1117-27.
25. Ling P, Ngo K, Nguyen S, Thurmond RL, Edwards JP, Karlsson L, Fung-Leung WP. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 2004; 142(1):161-71.
26. Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003; 305(3):1212-21.
27. Seligmann BE, Fletcher MP, Gallin JI. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. J Immunol 1983; 130(4):1902-9.
28. Bakker RA, Schoonus SB, Smit MJ, Timmerman H, Leurs R. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 2001; 60(5):1133-42.
29. Yoneda K, Yamamoto T, Ueta E, Osaki T. Suppression by azelastine hydrochloride of NF-kappa B activation involved in generation of cytokines and nitric oxide. Jpn J Pharmacol 1997; 73(2):145-53.
30. Ghosh AK, Hirasawa N, Ohtsu H, Watanabe T, Ohuchi K. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med 2002; 195(8):973-82.
31. Szeberenyi JB, Pallinger E, Zsinko M, Pos Z, Rothe G, Orso E, Szeberenyi S, Schmitz G, Falus A, Laszlo V. Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett 2001; 76(3):175-82.
32. Idzko M, la Sala A, Ferrari D, Panther E, Herouy Y, Dichmann S, Mockenhaupt M, Di Virgilio F, Girolomoni G, Norgauer J. Expression and function of histamine receptors in human monocyte-derived dendritic cells. J Allergy Clin Immunol 2002; 109(5):839-46.
33. Gutzmer R, Langer K, Lisewski M, Mommert S, Rieckborn D, Kapp A, Werfel T. Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J Allergy Clin Immunol 2002; 109(3):524-31.
34. Caron G, Delneste Y, Roelandts E, Duez C, Bonnefoy JY, Pestel J, Jeannin P. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001; 167(7):3682-6.
35. Gantner F, Sakai K, Tusche MW, Cruikshank WW, Center DM, Bacon KB. Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells. J Pharmacol Exp Ther 2002; 303(1):300-7.
36. Caron G, Delneste Y, Roelandts E, Duez C, Herbault N, Magistrelli G, Bonnefoy JY, Pestel J, Jeannin P. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J Immunol 2001; 166(10):6000-6.
37. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001; 108(12):1865-73.
38. van der Pouw Kraan TC, Snijders A, Boeije LC, de Groot ER, Alewijnse AE, Leurs R, Aarden LA. Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest 1998; 102(10):1866-73.
39. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998; 161(5):2586-93.
40. Takahashi HK, Iwagaki H, Mori S, Yoshino T, Tanaka N, Nishibori M. Histamine inhibits lipopolysaccharide-induced interleukin (IL)-18 production in human monocytes. Clin Immunol 2004; 112(1):30-4.
41. Takahashi HK, Morichika T, Iwagaki H, Tamura R, Kubo S, Yoshino T, Mori S, Akagi T, Tanaka N, Nishibori M. Histamine downregulates CD14 expression via H2 receptors on human monocytes. Clin Immunol 2003; 108(3):274-81.
42. Morichika T, Takahashi HK, Iwagaki H, Yoshino T, Tamura R, Yokoyama M, Mori S, Akagi T, Nishibori M, Tanaka N. Histamine inhibits lipopolysaccharide- induced tumor necrosis factor-alpha production in an intercellular adhesion molecule-1- and B7.1-dependent manner. J Pharmacol Exp Ther 2003; 304(2):624-33.
43. Ohtani T, Aiba S, Mizuashi M, Mollah ZU, Nakagawa S, Tagami H. H1 and H2 histamine receptors are absent on Langerhans cells and present on dermal dendritic cells. J Invest Dermatol 2003; 121(5):1073-9.
44. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, Zak-Nejmark T, Koga R, Kobayashi T, Blaser K, Akdis CA. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001; 413(6854):420-5.
45. Osna N, Elliott K, Khan MM. Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes. Int Immunopharmacol 2001; 1(1):85-96.
46. Banu Y, Watanabe T. Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling. J Exp Med 1999; 189(4):673-82.
47. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K. Role of IL-10 in specific immunotherapy. J Clin Invest 1998; 102:98-106.
48. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis C. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33(5):1205-14.
49. Kunzmann S, Mantel P-Y, Wohlfahrt J, Akdis M, Blaser K, Schmidt-Weber C. Histamine enhances TGF-beta1-mediated suppression of Th2 responses. Faseb J 2003; In Press.
50. Muller U, Hari Y, Berchtold E. Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. J Allergy Clin Immunol 2001; 107(1):81-6.
51. Jutel M, Zak-Nejmark T, Wrzyyszcz M, Malolepszy J. Histamine receptor expression on peripheral blood CD4+ lymphocytes is influenced by ultrarush bee venom immunotherapy. Allergy 1997; 52(suppl. 37):88.
52. Gifford R, Schmidke J. Cimetidine-induced augmentation of human lymphocyte blastogenesis: comparison with levamisole in mitogen stimulation. Surg Forum 1979; 30:113-5.
53. Gelfand EW, Cui ZH, Takeda K, Kanehiro A, Joetham A. Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. J Allergy Clin Immunol 2002; 110(1):85-95.
54. Bryce PJ, Geha R, Oettgen HC. Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma. J Allergy Clin Immunol 2003; 112(1):149-58.
55. Triggiani M, Gentile M, Secondo A, Granata F, Oriente A, Taglialatela M, Annunziato L, Marone G. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol 2001; 166(6):4083-91.
56. Panettieri RA, Yadvish PA, Kelly AM, Rubinstein NA, Kotlikoff MI. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J Physiol 1990; 259(6 Pt 1):L365-71.
57. Chand N, Eyre P. Classification and biological distribution of histamine receptor sub-types. Agents Actions 1975; 5(4):277-95.
58. Thomson NC, Kerr JW. Effect of inhaled H1 and H2 receptor antagonist in normal and asthmatic subjects. Thorax 1980; 35(6):428-34.
59. White JP, Mills J, Eiser NM. Comparison of the effects of histamine H1- and H2-receptor agonists on large and small airways in normal and asthmatic subjects. Br J Dis Chest 1987; 81(2):155-69.
60. Gonzales H, Ahmed T. Suppression of gastric H2-receptor-mediated function in patients with bronchial asthma and ragweed allergy. Chest 1986; 89:491-6.
61. Field SK, Sutherland LR. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature. Chest 1998; 114(1):275-83.
62. Sirois J, Menard G, Moses AS, Bissonnette EY. Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: stimulation of IL-10 production. J Immunol 2000; 164(6):2964-70.
63. Benovic J. Novel b2-adrenergic receptor signaling pathways. J Allergy Clin Immunol 2002; 110:s229-s35.